Suchergebnisse - "McClung, M"

PubPharm (262)

1

Treatment rates and healthcare costs of patients with fragility fracture by site of care : a real-world data analysis

enthalten in: Archives of osteoporosis | 2023

von Singer, A. | McClung, M. | Tran, O. | +5

2

Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis

enthalten in: Archives of osteoporosis | 2023

von Singer, A. | McClung, M. | Tran, O. | +5

3

Osteoanabolic therapy for osteoporosis in women

enthalten in: Climacteric : the journal of the International Menopause Society | 2022

von McClung, M. | Clark, A.

4

Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan

enthalten in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2021

von Hagino, H. | Tanaka, K. | Silverman, S. | +6

5

Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan

enthalten in: Osteoporosis international | 2021

von Hagino, H. | Tanaka, K. | Silverman, S. | +6

6

Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan

enthalten in: Osteoporosis international | 2021

von Hagino, H. | Tanaka, K. | Silverman, S. | +6

7

Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan

enthalten in: Osteoporosis international | 2021

von Hagino, H. | Tanaka, K. | Silverman, S. | +6

8

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

enthalten in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA | 2020

von McClung, M. | Bolognese, M. | Brown, J. | +7

9

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

enthalten in: Osteoporosis international | 2020

von McClung, M. | Bolognese, M. | Brown, J. | +7

10

A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab

enthalten in: Osteoporosis international | 2020

von McClung, M. | Bolognese, M. | Brown, J. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]